Abstract

The two Ral GTPases, RalA and RalB, have crucial roles downstream Ras oncoproteins in human cancers; in particular, RalB is involved in invasion and metastasis. However, therapies targeting Ral signalling are not available yet. By a novel optogenetic approach, we found that light-controlled activation of Ral at plasma-membrane promotes the recruitment of the Wave Regulatory Complex (WRC) via its effector exocyst, with consequent induction of protrusions and invasion. We show that active Ras signals to RalB via two RalGEFs (Guanine nucleotide Exchange Factors), RGL1 and RGL2, to foster invasiveness; RalB contribution appears to be more important than that of MAPK and PI3K pathways. Moreover, on the clinical side, we uncovered a potential role of RalB in human breast cancers by determining that RalB expression at protein level increases in a manner consistent with progression toward metastasis. This work highlights the Ras-RGL1/2-RalB-exocyst-WRC axis as appealing target for novel anti-cancer strategies.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Giulia Zago

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Irina Veith

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Manish Singh

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Laetitia Fuhrmann

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Simon De Beco

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Amanda Remorino

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Saori Takaoka

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Marjorie Palmeri

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Frédérique Berger

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Nathalie Brandon

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Ahmed El Marjou

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Anne Vincent-Salomon

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Jacques Camonis

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Mathieu Coppey

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  15. Maria Carla Parrini

    Institut Curie, Paris, France
    For correspondence
    maria-carla.parrini@curie.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7082-9792

Funding

Fondation ARC pour la Recherche sur le Cancer (PJA 20151203371)

  • Maria Carla Parrini

Institut National de la Santé et de la Recherche Médicale (PC201530)

  • Mathieu Coppey

Agence Nationale de la Recherche (ANR-10-IDEX-0001-02 PSL)

  • Mathieu Coppey

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Andrea Musacchio, Max Planck Institute of Molecular Physiology, Germany

Version history

  1. Received: July 31, 2018
  2. Accepted: October 14, 2018
  3. Accepted Manuscript published: October 15, 2018 (version 1)
  4. Version of Record published: November 9, 2018 (version 2)
  5. Version of Record updated: November 13, 2018 (version 3)

Copyright

© 2018, Zago et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,007
    views
  • 273
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Giulia Zago
  2. Irina Veith
  3. Manish Singh
  4. Laetitia Fuhrmann
  5. Simon De Beco
  6. Amanda Remorino
  7. Saori Takaoka
  8. Marjorie Palmeri
  9. Frédérique Berger
  10. Nathalie Brandon
  11. Ahmed El Marjou
  12. Anne Vincent-Salomon
  13. Jacques Camonis
  14. Mathieu Coppey
  15. Maria Carla Parrini
(2018)
RalB directly triggers invasion downstream Ras by mobilizing the Wave complex
eLife 7:e40474.
https://doi.org/10.7554/eLife.40474

Share this article

https://doi.org/10.7554/eLife.40474

Further reading

    1. Cell Biology
    Yoko Nakai-Futatsugi, Jianshi Jin ... Masayo Takahashi
    Research Article

    Retinal pigment epithelium (RPE) cells show heterogeneous levels of pigmentation when cultured in vitro. To know whether their color in appearance is correlated with the function of the RPE, we analyzed the color intensities of human-induced pluripotent stem cell-derived RPE cells (iPSC-RPE) together with the gene expression profile at the single-cell level. For this purpose, we utilized our recent invention, Automated Live imaging and cell Picking System (ALPS), which enabled photographing each cell before RNA-sequencing analysis to profile the gene expression of each cell. While our iPSC-RPE were categorized into four clusters by gene expression, the color intensity of iPSC-RPE did not project any specific gene expression profiles. We reasoned this by less correlation between the actual color and the gene expressions that directly define the level of pigmentation, from which we hypothesized the color of RPE cells may be a temporal condition not strongly indicating the functional characteristics of the RPE.

    1. Cancer Biology
    2. Cell Biology
    Savvas Nikolaou, Amelie Juin ... Laura M Machesky
    Research Article

    Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signaling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor-1. Overall, we implicate CYRI-B as a mediator of growth and signaling in pancreatic cancer, providing new insights into pathways controlling metastasis.